169 related articles for article (PubMed ID: 22528338)
1. Oblique approach for CT-guided liver radiofrequency ablation using multiplanar reformation images in hepatocellular carcinoma.
Kamei S; Matsuda J; Hagihara M; Kitagawa A; Izumi Y; Katsuda E; Oshima Y; Ikeda S; Kimura J; Ota T; Kawamura T; Ishiguchi T
Jpn J Radiol; 2012 Jul; 30(6):533-9. PubMed ID: 22528338
[TBL] [Abstract][Full Text] [Related]
2. Feasibility, safety, and efficacy of artificial carbon dioxide pneumothorax for computed tomography fluoroscopy-guided percutaneous radiofrequency ablation of hepatocellular carcinoma.
Shibamoto K; Mimura H; Fukuhara Y; Nishino K; Kawamoto H; Kato K
Jpn J Radiol; 2021 Nov; 39(11):1119-1126. PubMed ID: 34089475
[TBL] [Abstract][Full Text] [Related]
3. Computed tomography fluoroscopy-guided radiofrequency ablation following intra-arterial iodized-oil injection for hepatocellular carcinomas invisible on ultrasonographic images.
Takaki H; Yamakado K; Nakatsuka A; Yamada T; Uraki J; Kashima M; Yamanaka T; Shiraki K; Takei Y; Takeda K
Int J Clin Oncol; 2013 Feb; 18(1):46-53. PubMed ID: 22016114
[TBL] [Abstract][Full Text] [Related]
4. CT-guided radiofrequency ablation for hepatocellular carcinomas that were undetectable at US: therapeutic effectiveness and safety.
Park BJ; Byun JH; Jin YH; Won HJ; Shin YM; Kim KW; Park SJ; Kim PN
J Vasc Interv Radiol; 2009 Apr; 20(4):490-9. PubMed ID: 19328427
[TBL] [Abstract][Full Text] [Related]
5. The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (> 2 and < 5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion.
Kim YS; Lee WJ; Rhim H; Lim HK; Choi D; Lee JY
AJR Am J Roentgenol; 2010 Sep; 195(3):758-65. PubMed ID: 20729457
[TBL] [Abstract][Full Text] [Related]
6. Hepatic radiofrequency under CT-fluoroscopy guidance.
Laganà D; Carrafiello G; Mangini M; Lumia D; Mocciardini L; Chini C; Pinotti G; Cuffari S; Fugazzola C
Radiol Med; 2008 Feb; 113(1):87-100. PubMed ID: 18338130
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: utility of contrast-enhanced agent detection imaging.
Kim CK; Choi D; Lim HK; Kim SH; Lee WJ; Kim MJ; Lee JY; Jeon YH; Lee J; Lee SJ; Lim JH
Eur J Radiol; 2005 Oct; 56(1):66-73. PubMed ID: 15913940
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous radiofrequency ablation of hepatocellular carcinomas adjacent to the gallbladder with internally cooled electrodes: assessment of safety and therapeutic efficacy.
Kim SW; Rhim H; Park M; Kim H; Kim YS; Choi D; Lim HK
Korean J Radiol; 2009; 10(4):366-76. PubMed ID: 19568465
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Small Hepatocellular Carcinoma (≤2 cm) in the Caudate Lobe with Sequential Transcatheter Arterial Chemoembolization and Radiofrequency Ablation.
Hyun D; Cho SK; Shin SW; Rhim H; Koh KC; Paik SW
Cardiovasc Intervent Radiol; 2016 Jul; 39(7):1015-22. PubMed ID: 26975761
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic performance of contrast-enhanced computed tomography in the immediate assessment of radiofrequency ablation success in colorectal liver metastases.
Schraml C; Clasen S; Schwenzer NF; Koenigsrainer I; Herberts T; Claussen CD; Pereira PL
Abdom Imaging; 2008; 33(6):643-51. PubMed ID: 18175165
[TBL] [Abstract][Full Text] [Related]
11. Contrast-enhanced US-guided radiofrequency ablation of hepatocellular carcinoma.
Rajesh S; Mukund A; Arora A; Jain D; Sarin SK
J Vasc Interv Radiol; 2013 Aug; 24(8):1235-40. PubMed ID: 23796857
[TBL] [Abstract][Full Text] [Related]
12. Image-guided radiofrequency ablation of hepatocellular carcinoma (HCC): is MR guidance more effective than CT guidance?
Clasen S; Rempp H; Hoffmann R; Graf H; Pereira PL; Claussen CD
Eur J Radiol; 2014 Jan; 83(1):111-6. PubMed ID: 24161781
[TBL] [Abstract][Full Text] [Related]
13. Completeness of treatment in hepatocellular carcinomas treated with image-guided tumor therapies: Evaluation of positive predictive value of contrast-enhanced CT with histopathologic correlation in the explanted liver specimen.
Kim YS; Rhim H; Lim HK; Park CK; Lee WJ; Do YS; Cho JW
J Comput Assist Tomogr; 2006; 30(4):578-82. PubMed ID: 16845287
[TBL] [Abstract][Full Text] [Related]
14. No-Touch Multi-bipolar Radiofrequency Ablation for the Treatment of Subcapsular Hepatocellular Carcinoma ≤ 5 cm Not Puncturable via the Non-tumorous Liver Parenchyma.
Petit A; Hocquelet A; N'kontchou G; Varin E; Sellier N; Seror O; Sutter O
Cardiovasc Intervent Radiol; 2020 Feb; 43(2):273-283. PubMed ID: 31673728
[TBL] [Abstract][Full Text] [Related]
15. Small- and medium-sized hepatocellular carcinomas: monopolar radiofrequency ablation with a multiple-electrode switching system-mid-term results.
Woo S; Lee JM; Yoon JH; Joo I; Kim SH; Lee JY; Yoon JH; Kim YJ; Han JK; Choi BI
Radiology; 2013 Aug; 268(2):589-600. PubMed ID: 23513241
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular carcinoma after radiofrequency ablation therapy: dynamic CT evaluation of treatment.
Tsuda M; Majima K; Yamada T; Saitou H; Ishibashi T; Takahashi S
Clin Imaging; 2001; 25(6):409-15. PubMed ID: 11733155
[TBL] [Abstract][Full Text] [Related]
17. Computed Tomography-guided Radiofrequency Ablation for Sub-diaphragm Hepatocellular Carcinoma: Safety and Efficacy of Inducing an Artificial Pneumothorax.
Fujiwara H; Arai Y; Ishii H; Kanazawa S
Acta Med Okayama; 2016 Jun; 70(3):189-95. PubMed ID: 27339208
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous radiofrequency ablation with multiple electrodes for medium-sized hepatocellular carcinomas.
Lee J; Lee JM; Yoon JH; Lee JY; Kim SH; Lee JE; Han JK; Choi BI
Korean J Radiol; 2012; 13(1):34-43. PubMed ID: 22247634
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous US/MRI Fusion-guided Radiofrequency Ablation for Recurrent Subcentimeter Hepatocellular Carcinoma: Technical Feasibility and Therapeutic Outcomes.
Song KD; Lee MW; Rhim H; Kang TW; Cha DI; Sinn DH; Lim HK
Radiology; 2018 Sep; 288(3):878-886. PubMed ID: 29916771
[TBL] [Abstract][Full Text] [Related]
20. Radiofrequency ablation for hepatocellular carcinoma: utility of conventional ultrasound and contrast-enhanced ultrasound in guiding and assessing early therapeutic response and short-term follow-up results.
Du J; Li HL; Zhai B; Chang S; Li FH
Ultrasound Med Biol; 2015 Sep; 41(9):2400-11. PubMed ID: 26055968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
